Tuberculosis (TB) is the world’s deadliest infectious disease, killing over a million people annually. While the century-old BCG vaccine protects young children, it leaves adolescents and adults vulnerable—and they’re the ones who are most likely to spread TB. New vaccines targeting this gap could arrive by 2030, but countries, manufacturers, and funders need to prepare... The post Forecasting global demand for life-saving TB vaccines appeared first on Clinton Health Access Initiative.
